|
The Stone Pain
Lab is a research laboratory at
McGill University headed by Laura S
Stone, PhD.
>> more about
Dr Stone >>
|
The lab's research
objective is to improve
diagnosis and treatment
of chronic pain by
expanding our
understanding of its
neurochemistry and
neuropathology. |
Analgesic
Pharmacology
Many analgesic
drugs such as those acting at opioid-
or alpha-2-adrenergic receptors
interact in a synergistic manner
when co-administered in humans or in
animal models. This is a important
clinically as co-administration of
synergistically interacting agents
can help maximize analgesia while
minimizing adverse side effects. A
major goal of my research is to
elucidate the underlying mechanism(s)
analgesic drug interactions using a
multidisciplinary approach that
includes behavioral, biochemical,
anatomical. electrophysiological and
genetic methods. We are currently
investigating the hypothesis that
the formation of hetero-oligomeric
receptor complexes represents a
molecular mechanism underlying
synergy.
Chronic Back Pain
Persistent back
pain is the most common chronic pain
condition in Canadians age 65 and
under. Unfortunately, the vast
majority of individuals suffer for
years with little relief. This is
due, in part, to a lack of
understanding of the underlying
causes of back pain. In order to
enhance our understanding, we are
developing a rodent model of back
pain due to degeneration of the
spine. Such a model will allow for
the identification and testing of
novel therapeutic interventions for
the alleviation of chronic back
pain.
In collaboration with colleagues
from the University of Minnesota, we
are developing a research program to
characterize the biochemical and
anatomical changes that accompany
different human chronic pain
conditions. We are currently focused
on low back pain patients who are
scheduled for spinal surgery to
remove degenerated lumbar discs for
therapeutic reasons. Following
documentation of disease type and
severity by physical examination we
will compare samples of cerebral
spinal fluid from these patients
with normal controls for
pain-related changes in expression
of known pro- and anti-nociceptive
compounds (i.e. Nerve Growth Factor,
Substance P). Cutting edge
proteomics methods (i.e. LC-MS/MS)
will be utilized for more
comprehensive characterization of
differentially expressed biomarkers,
many of which may be currently
unidentified. Anatomical studies
will be performed on lumbar discs
(removed as part of surgical
treatment) for inflammatory
involvement and pathological
innervation patterns. |
|
2009: L.S. Stone.
Joint degeneration and chronic pain: Still looking for
the missing link (Editorial), Pain, 141(1):185-186.

2009: M.S. Riedl, S. Schnell, A.C. Overland, A-J. Chabot-Dore, A.M.
Taylor, A. Ribeiro-Da-Silva, R. Elde, G.L. Wilcox and
L.S. Stone.
Co-expression of Alpha-2a-adrenergic and delta-opioid
receptors in Substance P containing terminals in rat
dorsal horn. Journal of Comparative Neurology,
513(4):385-398.

Ms. Anne-Julie Chabot-Dore
received a Returning Studentship from the McGill
Graduate Program in Neuroscience.

Ms. Anne-Julie Chabot-Dore,
Mr. Tony Lim and Dr. Magali Millecamps received trainee
travel awards from the International Association for the
Study of Pain to attend the 12th World Congress on Pain
in Glasgow in August 2008.

Dr Stone has been awarded the FRSQ,
Chercheur-boursier - Fondamental - Junior 2 Salary Award
for the project "Rôle des récepteurs ŕ sept domaines
transmembranaires dans la douleur et l'antalgie: actions
et interactions."
|
|
|